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Background: We report a rare case of three head and neck malignancies in one patient. Squamous cell carcinoma
of tongue and papillary thyroid carcinoma occurred as metachronous cancers in a patient with primary
nasopharyngeal carcinoma. These three pathologically distinct malignancies of head and neck region in one patient
is a rare phenomenon and is not reported so far.
Case presentation: A 60 year old Saudi female patient presented in March 2011 with locally advanced
nasopharyngeal carcinoma. After completion of concurrent chemoradiation in June 2011, she developed two new
primaries i-e thyroid cancer and tongue cancer in May 2012 along with recurrent nasopharyngeal carcinoma. We
discuss histopathologic features, diagnostic tools and treatment modalities for this rarely existing case.
Conclusion: High index of suspicion and thorough work up is essential in follow up of patients with head and
neck primary cancers. The effect of field cancerization and environmental factors need to be explored in greater
depths in such selected cases. However, which patients are at increased risk of triplet primaries, is still unknown.
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The incidence of three primary cancers in one patient,
whether synchronous (simultaneous) or metachronous
(successive) is rare, especially if it comes to malignancies
appearing in head and neck region. It is always import-
ant for the treating oncologists to keep in mind the pos-
sibility of a synchronous or a metachronous malignancy
in a cancer patient. Patients with head and neck primary
cancers have increased propensity of having second can-
cers especially in patients with tongue, pyriform sinus,
larynx, oral cavity and tonsillar cancers. Schwartz et al.,
observed 19% incidence of second cancers in the same
region in patients presenting with primary head and
neck cancers. Among them, 41% were synchronous and
59% were metachronous [1]. As the development of a
second malignancy is almost always fatal, there is a need
for additional efforts in work up, radiation treatment* Correspondence: mfareed@kfmc.med.sa
1Department of Radiation Oncology, King Fahad Medical City, Riyadh 11525,
Saudi Arabia
Full list of author information is available at the end of the article
© 2013 Fareed et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orplanning, goals of treatment and follow up schedules in
such a group of patients [1,2].
Although there have been reports of second cancers
arising within the context of primary head and neck can-
cer, the incidence of three head and neck primary can-
cers is extremely rare, if not extinct. Among head and
neck tumors, nasopharynx, larynx and hypopharynx
have been described as having increased incidence of
triplicate malignancies [3].
Our case is therefore worth mentioning as it reports
three different primary cancers in a single patient arising
in nasopharynx, tongue and thyroid. Interesting was the
fact that these three primaries were with three different
histologies: Undifferentiated carcinoma of nasopharynx,
squamous cell carcinoma of tongue and papillary carcinoma
of thyroid. The incidence of multiple primary malignant
neoplasms increases with age and they are encountered
more frequently nowadays than before owing to better diag-
nostic approaches. Although the scattered reports of devel-
oping three primaries have been described for other body
sites, this is by far the first case mentioning three different
malignancies in head and neck region [4].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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head and neck malignancies, i.e. nasopharyngeal, tongue
and papillary thyroid carcinoma.
Case presentation
Case report
A 60 years Saudi lady, known diabetic and hypertensive,
presented on March 10, 2011 to Otorhinolaryngology
department of King Fahad Medical City Riyadh. She had
history of left sided nasal obstruction, decreased left
sided hearing and blood tinged sputum for last 3
months. Nasendoscopy showed left sided nasopharyn-
geal mass, biopsy of which showed undifferentiated car-
cinoma on March 20th, 2011 Figure 1. She underwent
complete staging work up including computed tomog-
raphy (CT) of head & neck, chest and abdomen which
showed predominantly left nasopharyngeal mass infil-
trating into the parapharyngeal space without skull
base or intracranial extension along with left internal
jugular and spinal accessory lymph nodes Figure 2.
The thyroid gland was slightly enlarged with a few bi-
lateral calcified nodules likely representing a multinodular
goiter. Further neck ultrasonography showed similar thy-
roid gland findings due to almost negligible index of suspi-
cion for malignancy. Thyroid function tests (TFTs),
serum thyroglobulin (TG) and serum calcium levels
were within normal limits. FNAC of thyroid nodules
was not performed at that time due to almost negligible
index of suspicion for malignancy. Remaining staging
work up was negative for distant metastases. After being
discussed in multidisciplinary tumor board meeting, she
was staged as T2N1M0 nasopharyngeal carcinoma and
referred to Radiation Oncology and Medical Oncology
departments for concurrent chemoradiation (CCRT) after
dental clearance and audiology assessment. She com-
pleted 70 Gy/35 fractions using intensity modulated ra-
diation therapy along with weekly Cisplatin 40 mg/m2 onFigure 1 Undifferentiated nasopharyngeal carcinoma WHO G-III.June 18th, 2011 Figure 3. During CCRT course of treat-
ment was tolerated with GI skin desquamation and
mucositis. After the completion of treatment, at 3
months there was complete resolution of primary nasopha-
ryngeal mass and neck nodes as evidenced by endoscopy,
CT and magnetic resonance imaging (MRI).
On May 6th, 2012, during her routine follow up, she
complained of ulcer over left tongue increasing in size
over 2 months and was painful even after taking analge-
sics. On examination, there was 1 cm ulcer over left lat-
eral tongue without any palpable lymphadenopathy (no
clinical photograph available as she refused) and delayed
GII radiation induced xerostomia. CT head and neck
showed new fullness along left nasopharyngeal wall with
some localized contrast enhancement and bulging of
mucosal contour without any obvious cervical lymph-
adenopathy and multiple heterogeneous nodules with
dystrophic calcification seen within both thyroid lobes
Figure 4. Impression was that of a possibility of a recur-
ring local tumor. For left sided tongue lesion, excisional
biopsy was performed due to its small size on June 9th,
2012 which showed invasive squamous cell carcinoma
Figure 5. Clinical stage for tongue squamous carcinoma
was labeled as cT1N0M0. FNAC from nasopharynx con-
firmed recurrent nasopharyngeal carcinoma of undifferen-
tiated type. On June 12, 2012, ultrasound guided FNAC of
thyroid nodule was also done which revealed papillary
thyroid carcinoma. Magnetic resonance imaging (MRI) of
head and neck was performed which showed previously
noted nasopharyngeal fullness increasing in size along with
well-defined mass tissue lesion at the posterior and superior
wall of the nasopharynx measuring 22 ×20 mm bulging
into the nasopharyngeal airway. Also infiltrating enhancing
lesion along the left border of the tongue was noted and en-
larged thyroid gland with multiple nodules. There was no
cervical lymphadenopathy or other distant metastases.
On June 17th 2012, her case was discussed again in
multidisciplinary tumor board meeting and the panel of
experts agreed to go for surgery of three sites. On August
11th 2012, she underwent total thyroidectomy, left partial
glossectomy with left lateral and central neck dissection
and nasopharyngeal tumor resection. In partial glossect-
omy, margins were sent as fresh frozen. All the margins
came out negative; except the anterior margin which
showed mild to moderate dysplasia. Detailed histopath-
ology report showed multifocal moderately differentiated
squamous cell carcinoma of the tongue, 1.1 cm in max-
imum dimension, depth of invasion 2 mm, negative peri-
neural and lymphovascular invasion, 0/12 lymph nodes
(pT1N0). Nasopharyngeal mass was positive for undiffer-
entiated nasopharyngeal carcinoma, WHO Grade –III,
while thyroid specimen showed papillary thyroid carcin-
oma, conventional type, tumor size 2.2 cm in maximum
dimension, positive extrathyroid extension in soft tissue,
Figure 2 CT showing (a) Left sided nasopharyngeal tumor infiltrating into the left parapharyngeal space and abutting the left internal
carotid artery and (b) Thyroid nodule right lobe.
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Figure 6; tumor was about 1 mm from inked resection
margin (Thyroid carcinoma staged as T2N0M0). On
November 13th 2012, she was given 100 milli curie (mCi)
radioactive iodine. Seven-day postablation whole bodyFigure 3 Intensity modulated radiation therapy (IMRT) for nasopharyngescintigraphy revealed two foci of post-thyroidectomy
residual functioning thyroid tissue in the neck. No distant
metastatic lesions were noted. Recurrent nasopharyngeal
primary was treated with stereotactic radiotherapy with
total dose 60 Gy in 30 fractions that completed on Januaryal carcinoma showing isodose distribution (a) 50 Gy and (b) 70 Gy.
Figure 4 CT head and neck showing recurrent left
nasopharyngeal wall mass with some localized contrast
enhancement and bulging of mucosal contour without any
obvious cervical lymphadenopathy.
Figure 6 Papillary thyroid carcinoma showing growth pattern
represented by finger-like projections lined by neoplastic cells.
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was found asymptomatic with GII late xerostomia.
Discussion
Multiple primary cancers are a rare entity whose etiology
is not well understood although some pathogenic factors
like persistent carcinogenic influence, field cancerization,
increasing use of systemic chemotherapy or radiotherapy,
hormonal manipulation, targeted therapy, genetic alter-
ation, immune suppression, tissue transplantation and
improved survival are implicated. The incidence of sec-
ond primary synchronous or metachronous tumor is
increasing and reported as high as 10%. A metaFigure 5 Moderately differentiated, multifocal squamous cell
carcinoma tongue.analyses shows the frequency of second primary tumor
as 3-5%, a third primary tumor as 0.5%, and a fourth pri-
mary tumor as 0.3% [5].
The second tumor is called synchronous if it is
found simultaneously or within six months of the
diagnosis of primary. All malignancies found later
than six months after the primary are considered as
metachronous [6]. In a study by Panosetti et al. on
855 patients of multiple primary head and neck can-
cer patients, 42% had synchronous while 58% had
metachronous tumors. Survival rates varied according
to the treatment as evident by the fact that 5 year
survival was only 8% among those synchronous tu-
mors in whom treatment was modified whereas it was
28% in patients with unmodified treatment plans [7]. An-
other study done on 796 patients showed that second
primaries were mostly found in esophagus, hypophar-
ynx, buccal cavity, and the lung. Incidence of multiple
cancers and synchronous primaries were more preva-
lent in prospective studies rather than in retrospective
series. The five-year survival rate among patients with
synchronous cancers in these two studies was 18% as
compared to those with metachronous cancers (41-
55%). The prognosis for synchronous cancers deterio-
rated if the planned treatment had to be modified
following the discovery of a second primary.
Individuals with a history of multiple cancers should
have a complete family history evaluation and follow-up
for development of subsequent primaries. Genetic coun-
seling, risk estimation, and cancer screening must be
emphasized. Every subsequent occurring tumor must be
biopsied [1]. There are different diagnostic modalities to
consider in such cases. Systematic pretherapeutic
panendoscopy should be used to help detect early asymp-
tomatic second primaries which might be missed during
clinical examination [8]. Because of the relatively small
Figure 7 Stereotactic radiation therapy for recurrent nasopharyngeal carcinoma.
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data on its effect on survival rates, the value of panendo-
scopy has been debated. However, its significance is often
crucial for the individual patient, despite the low proportion
of positive findings. The study by Hujala K. et al. included
203 consecutive patients with squamous cell cancer of the
upper aerodigestive tract who underwent panendoscopy in
Turku University Central Hospital as part of the initial
diagnostic workup from 1992–1999. Eight patients with
synchronous second primaries and 19 patients with meta-
chronous tumors were diagnosed [9]. Haughty et al. rec-
ommended routine interval endoscopic intervention
within 2 years of treatment for optimum detection of
second primaries in head and neck cancer patients.
Also, a lifetime of clinical surveillance is suggested for
aerodigestive tract second neoplasms in oral cavity,
oropharynx, and hypopharynx cancer patients and for
lung and non-aerodigestive tract neoplasms in larynx
cancer patients based on their meta-analysis of second
malignant tumors in head and neck cancers. Head and
neck second primary tumors were more common in
oral cavity, oropharynx and hypopharynx [10].In the long run, prevention has to play a decisive role
in the fight against second primary tumors of the upper
aerodigestive tract. Possible improvements in early diag-
nosis, genetic examinations, information campaigns as
well as research of carcinogenic environmental pollutants
are of foremost interest to the clinician [11]. Screening
programs and chemoprevention strategies should be
directed toward cancer patients with initial head and
neck malignancies [9]. The effect of first tumor on the
2nd primary or vice versa is still not fully understood
and need to be explored. The second primary tumor is
usually more aggressive, more treatment resistant, and
metastasizes early, requiring a more aggressive treat-
ment strategy [5].
Our patient had metachronous tumors (tongue cancer
and thyroid cancer) arising almost one year after the
primary diagnosis of nasopharyngeal carcinoma. It was
associated with recurrence at the primary site also. It
emphasizes the need for vigilant, regular and meticulous
follow up of such patients along with appropriate imaging
and biopsy techniques. The efficacy of 18F-FDG PET/CT
has been discussed in detection of distant metastases in
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detecting synchronous and metachronous lesions of the
same region is not clear [12]. The role of panendoscopy
and subsequent biopsy of suspicious lesion is more
compromising. Such early suspicious lesions should be
biopsied as early as possible in order to offer best curative
modality to these patients. The prognosis in such patients
is obviously not as good as in patients with primary cancers.
The burden of interventional investigations and com-
plication rates are also obviously high in these patients.
The prognosis of synchronous tumors is significantly lower
when compared to malignancies of a metachronous nature,
despite some encouraging individual results. Only the early
implementation of aggressive treatment methods for sec-
ond primaries is successful in terms of survival [13].Conclusions
Three primaries in head and neck region are rare and this
is by far the first case reporting metachronous thyroid and
tongue cancers in a patient with primary nasopharyngeal
carcinoma. Careful follow up with special emphasis on
early detection of any subsequent primary tumors is very
critical in patients presenting with head and neck cancers.
Role of panendoscopy and PET is controversial but can be
of substantial help in this regard.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
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